Indian health activists criticise voluntary price cuts by drug industryBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39031.665868.DB (Published 16 November 2006) Cite this as: BMJ 2006;333:1036
- Ganapati Mudur
- 1New Delhi
Some of India's largest drug companies have reduced the prices of 886 drug formulations, but health activists and some doctors have described the move as a ploy by the drug industry to evade meaningful price control.
The government last week released a list of formulations for which the drug companies have voluntarily reduced the prices by amounts ranging from 0.26% to 74% below current prices.
Officials at the Indian Ministry of Chemicals have said that the 11 companies submitted individual lists in response to ongoing government initiatives to work with industry to reduce the retail price of drugs.
The formulations …